AstraZeneca

OTC: AZNCF · Real-Time Price · USD
155.50
-0.25 (-0.16%)
At close: Aug 15, 2025, 3:42 PM
155.75
0.16%
After-hours: Aug 13, 2025, 08:00 PM EDT

AstraZeneca Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
9.61B 8.42B 7.59B 6.91B 6.74B 6.89B 6.99B 6.78B 6.05B 4.21B 2.5B 1.09B -1.84B -1.32B -265M 1.54B 4.39B 4.59B
Depreciation & Amortization
6.86B 6.75B 6.68B 5.71B 5.17B 5.17B 5.42B 5.54B 5.59B 5.67B 5.48B 6.19B 7.65B 7.04B 6.53B 5.13B 3.15B 3.1B
Stock-Based Compensation
n/a n/a n/a 579M 579M 579M 579M 619M 619M 619M 619M 615M 615M 615M 615M 277M 277M 277M
Other Working Capital
-1.09B -874.89M -893M -693M 163M -697M n/a -3.31B -3.14B -1.56B n/a 1.4B 1.53B 594M n/a 2.32B 1.64B 1.66B
Other Non-Cash Items
-1.99B -1.2B 1.06B 1.81B 1.39B 732.32M -2.24B -2.41B -2.08B -2.37B -1.93B -1.87B -1.75B -1.08B -2.32B -3.01B -3.09B -3.12B
Deferred Income Tax
n/a n/a n/a -579M -579M -579M -579M -619M -619M -619M -619M n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.09B -874.89M -890.97M -387.59M 468.41M -391.59M 303.39M 449M 619M 2.19B 3.76B 3.42B 3.56B 2.62B 2.02B 2.68B 2B 2.02B
Operating Cash Flow
13.39B 13.09B 11.94B 11.54B 11.27B 9.91B 10.47B 10.36B 10.18B 9.71B 9.81B 8.83B 7.62B 7.26B 5.96B 6.34B 6.45B 6.59B
Capital Expenditures
-4.68B -3.42B -4.58B -4.59B -4.11B -3.92B -3.8B -3.39B -3.62B -3.68B -2.57B -2.73B -2.28B -2.09B -2.2B -2.03B -2.08B -2.7B
Cash Acquisitions
-1.18B -3.22B -3.74B -3.78B -3.77B -1.65B -1.19B -1.07B -1.14B -1.25B -1.06B -1.09B -10.38B -10.22B -9.43B -9.37B -57M -105M
Purchase of Investments
-217M 2M -95.56M -192.67M -258.67M -315.67M -985.1M -698M -924M -922M -159M -343M -202M -188M -239.03M -245.03M -65.03M -59.03M
Sales Maturities Of Investments
130.42M 100.42M 59.58M 190.47M 75.47M 72.47M 131.29M 214M 280M 190M 224M 27M 14M 130M 105M 595M 849M 1.87B
Other Investing Acitivies
-2.01B -1.21B -1.23B -977.49M -49.49M 349.16M 1.67B 1.71B 1.65B 1.62B 607M -241M -1.04B -916M -1.11B -196M 287M -1.11B
Investing Cash Flow
-6.06B -6.82B -8.06B -8.06B -7.77B -5.41B -4.17B -3.24B -3.76B -4.04B -2.96B -3.62B -12.35B -11.78B -11.06B -10.01B -123M 261M
Debt Repayment
-1.27B -3.02B 749.31M 1.12B 2.34B 2.02B -1.12B -947.12M 192M 393M -1.44B -2.27B -625M 7.96B 7.84B 7.09B 7.96B 1.8B
Common Stock Repurchased
318.78M 318.78M 817.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-5.02B -5.03B -4.62B -4.62B -4.41B -4.41B -4.49B -4.58B -4.52B -4.59B -4.47B -4.38B -4.47B -4.39B -3.89B -3.87B -3.66B -3.64B
Other Financial Acitivies
-154.23M -140.54M -73.31M -38.73M -108.61M -125.45M -982.68M -1.24B -1.1B -1.05B -1.05B -875.63M -955.63M -955.63M -332.51M -770.89M -760.89M -754.89M
Financial Cash Flow
-6.99B -8.73B -4.01B -3.62B -2.22B -2.51B -6.56B -6.63B -5.34B -5.11B -6.82B -7.52B -5.94B 2.64B 3.65B 2.49B 3.59B -2.57B
Net Cash Flow
355M -2.48B -259.65M -289.5M 1.1B 1.76B -399.85M 433M 991M 475M -55M -2.39B -10.72B -1.88B -1.51B -1.22B 9.89B 4.26B
Free Cash Flow
8.88B 9.95B 7.48B 7.07B 7.28B 5.98B 6.67B 6.98B 6.56B 6.03B 7.24B 6.09B 5.33B 5.17B 3.76B 4.31B 4.37B 3.9B